Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Sep;36(9):1715-1717.
doi: 10.1038/s41433-022-01949-z. Epub 2022 Jan 31.

The clinician's guide to interpreting a regression analysis

Sofia Bzovsky  1 , Mark R Phillips  2 , Robyn H Guymer  3   4 , Charles C Wykoff  5   6 , Lehana Thabane  2   7 , Mohit Bhandari  1   2 , Varun Chaudhary  8   9 ; R.E.T.I.N.A. study group
Collaborators, Affiliations
Editorial

The clinician's guide to interpreting a regression analysis

Sofia Bzovsky et al. Eye (Lond). 2022 Sep.
No abstract available

PubMed Disclaimer

Conflict of interest statement

SB: Nothing to disclose. MRP: Nothing to disclose. RHG: Advisory boards: Bayer, Novartis, Apellis, Roche, Genentech Inc.—unrelated to this study. CCW: Consultant: Acuela, Adverum Biotechnologies, Inc, Aerpio, Alimera Sciences, Allegro Ophthalmics, LLC, Allergan, Apellis Pharmaceuticals, Bayer AG, Chengdu Kanghong Pharmaceuticals Group Co, Ltd, Clearside Biomedical, DORC (Dutch Ophthalmic Research Center), EyePoint Pharmaceuticals, Gentech/Roche, GyroscopeTx, IVERIC bio, Kodiak Sciences Inc, Novartis AG, ONL Therapeutics, Oxurion NV, PolyPhotonix, Recens Medical, Regeron Pharmaceuticals, Inc, REGENXBIO Inc, Santen Pharmaceutical Co, Ltd, and Takeda Pharmaceutical Company Limited; Research funds: Adverum Biotechnologies, Inc, Aerie Pharmaceuticals, Inc, Aerpio, Alimera Sciences, Allergan, Apellis Pharmaceuticals, Chengdu Kanghong Pharmaceutical Group Co, Ltd, Clearside Biomedical, Gemini Therapeutics, Genentech/Roche, Graybug Vision, Inc, GyroscopeTx, Ionis Pharmaceuticals, IVERIC bio, Kodiak Sciences Inc, Neurotech LLC, Novartis AG, Opthea, Outlook Therapeutics, Inc, Recens Medical, Regeneron Pharmaceuticals, Inc, REGENXBIO Inc, Samsung Pharm Co, Ltd, Santen Pharmaceutical Co, Ltd, and Xbrane Biopharma AB—unrelated to this study. LT: Nothing to disclose. MB: Research funds: Pendopharm, Bioventus, Acumed—unrelated to this study. VC: Advisory Board Member: Alcon, Roche, Bayer, Novartis; Grants: Bayer, Novartis—unrelated to this study.

References

    1. Schneider A, Hommel G, Blettner M. Linear Regression. Anal Dtsch Ärztebl Int. 2010;107:776–82. - PMC - PubMed
    1. Bender R. Introduction to the use of regression models in epidemiology. In: Verma M, editor. Cancer epidemiology. Methods in molecular biology. Humana Press; 2009:179–95. - PubMed
    1. Schober P, Vetter TR. Confounding in observational research. Anesth Analg. 2020;130:635. doi: 10.1213/ANE.0000000000004627. - DOI - PubMed
    1. Schober P, Vetter TR. Linear regression in medical research. Anesth Analg. 2021;132:108–9. doi: 10.1213/ANE.0000000000005206. - DOI - PMC - PubMed
    1. Szumilas M. Explaining odds ratios. J Can Acad Child Adolesc Psychiatry. 2010;19:227–9.. doi: 10.1007/s00787-010-0087-7. - DOI - PMC - PubMed

Publication types